Part,  Chapter, Paragraph

 1    I,     2.  5       |    published in early October 2003, presented a panorama of recent developments
 2   II,     5.  2.  2   |           years) mortality rate are presented as average of the last 3
 3   II,     5.  2.  4   |       events’ (EUROASPIRE) surveys, presented by the European Society
 4   II,     5.  3.  3   |            mortality, survival) are presented here subdivided per selected
 5   II,     5.  3.  3   |           208). Each cancer site is presented according to the following
 6   II,     5.  3.  3   |          and relative survival data presented in the following paragraphs
 7   II,     5.  3.  6   |          macro-analysis results are presented. The results of various
 8   II,     5.  4.  2   |      considerable attention and are presented in Tables 5.4.3 and 5.4.
 9   II,     5.  4.  6   |           Nurses in Diabetes (FEND) presented the paperDiabetes: EU
10   II,     5.  5.  1   |          disorders and suicides are presented below accordingly. For more
11   II,     5.  5.  1   |            Annual national data are presented as absolute numbers, crude
12   II,     5.  5.  1   |            of the ESEMeD survey are presented in Chapter 5.5.1. Mental
13   II,     5.  5.  1   |           Eurobarometer surveys are presented in detail in Chapter 5.5.
14   II,     5.  5.  1   |       difficult. HBSC and SHARE are presented in more detail in Chapter
15   II,     5.  5.  1   |            the subjects interviewed presented a high level of psychological
16   II,     5.  5.  1   |          young people aged 15 to 24 presented lower risks than older adults.
17   II,     5.  5.  1   |            and gender in Europe are presented in Table 5.5.1.6.~ ~Table
18   II,     5.  5.  2   |             Data sources~ ~The data presented here is taken from two major
19   II,     5.  5.  2   |           the brain. The statistics presented here are therefore based
20   II,     5.  5.  2   |           already seem, the figures presented in this report are likely
21   II,     5.  5.  3   |              the data are generally presented in published Yearly Statistical
22   II,     5.  5.  3   |      disease burden. Hence the data presented are supplemented by data
23   II,     5.  5.  3   |      retrospectively assessed, were presented as total annual cost per
24   II,     5.  5.  3   |       disability is most frequently presented as Kurtzke’s Expanded Disability
25   II,     5.  5.  3   |             contents of the report, presented by Parliament’s Rapporteur
26   II,     5.  5.  3   |            onset.~Similar data were presented by the German federal department
27   II,     5.  7.  1   |          possible, the CKD data are presented according to the internationally
28   II,     5.  7.  1   |           about CKD in children are presented according to available GFR
29   II,     5.  7.  5   |           CKD in an early phase was presented to a Parliamentary Health
30   II,     5.  8.  2   |             Data sources~ ~The data presented in this section are:~- Data
31   II,     5.  8.  4   |           with the smoking habit is presented in Figure 5.8.3.~ ~Figure
32   II,     5.  8.  5   |           study performed in Poland presented a promising approach for
33   II,     5.  9. FB   |            2. Data sources~The data presented in this section are:~- derived
34   II,     5.  9.  2   |           Data sources~ ~ ~The data presented in this section are:~- Data
35   II,     5.  9.  3   |             asthma, such as Greece, presented also a low prevalence of
36   II,     5.  9.  3   |      adolescents 13 to 14 years old presented a 37.1% prevalence. The
37   II,     5.  9.  3   |     prevalence. The other countries presented the following prevalence
38   II,     5.  9.  4   |             and serological assays) presented a low frequency of both
39   II,     5. 15.  3   |        prevalence figures typically presented in Europe. However, the
40   II,     6.  2       |          Data sources~ ~The results presented here are mainly based on
41   II,     6.  2.  0(1)|                         The results presented here are from the Executive
42   II,     6.  3.  2   |        visible the way the data are presented. A prerequisite to be able
43   II,     7.  4       |   indicators. Only some of the data presented in the previous section
44   II,     7.  4.  3   |         road users, EU25~ ~The data presented is taken from the report
45   II,     8.  2.  1   |        Lantman-de Valk et al (2007) presented evidence that patients with
46   II,     8.  2.  3   |           impact in performance are presented in Table 8.4. Available
47   II,     9.  1.  1   |            fetal mortality rates be presented for infants 1000 or more.~
48   II,     9.  1.  1   |             recommends that data be presented separately by gestational
49   II,     9.  1.  1   |            other published data are presented here to show how these indicators,
50   II,     9.  1.  1   |            congenital anomalies are presented elsewhere in this volume
51   II,     9.  1.  1   |         research (SCPE, 2000). Data presented here concern children with
52   II,     9.  1.  1   |              First of all, the data presented in this chapter reveal significant
53   II,     9.  1.  1   |    regarding reproduction issues is presented in Chapter 9.3.2~ ~
54   II,     9.  1.  1   |            Infant Mortality. Papers presented at the Second International
55   II,     9.  1.  2   |          high for some anomalies as presented in section 9.1.2.3. Comparisons
56   II,     9.  1.  2   |        primary prevention have been presented in Table 9.1a. The following
57   II,     9.  2.  3(2)|       number of arguments have been presented to support this approach.
58   II,     9.  3.  1   |          However, even when data is presented broken down by sex, there
59   II,     9.  3.  1   |       nature of much of the disease presented. There have been just two
60   II,     9.  3.  1   |            those bodily perceptions presented as complaints by the individual
61   II,     9.  3.  1   |           ways in which results are presented (Hunsche et al, 2001). More
62   II,     9.  3.  1   |            EGM/Health/1998/Report). Presented at the UN DAW Expert Group
63   II,     9.  3.  2   |           maternal health have been presented in Chapter 9.1.1.2.~ ~
64   II,     9.  3.  2   |            Infant Mortality. Papers presented at the Second International
65   II,     9.  3.  3   |            countries and regions is presented in the Health Behaviour
66   II,     9.  5.  6   |            EGM/Health/1998/Report). Presented at the UN DAW Expert Group
67  III,    10.  1.  1   |         adjusted results have to be presented (McClelland and Judd, 1993;
68  III,    10.  2.  1   |            attributed to smoking is presented in Table 10.2.1.1.3., for
69  III,    10.  2.  1   |        population surveys have been presented in Table 10.2.3.1.~ ~Table
70  III,    10.  2.  1   |             Prevention is sometimes presented as the main priority in
71  III,    10.  2.  1   |   description of the drug situation presented above was possible through
72  III,    10.  2.  1   |            main surveys are briefly presented.~ ~Global surveys including
73  III,    10.  2.  1   |         urban mobility that will be presented in early autumn 2008. This
74  III,    10.  3.  1   |          exposure. With the numbers presented above, radon is clearly
75  III,    10.  3.  2   | perflourinated substances (PFS) are presented as examples because of their
76  III,    10.  4.  2   |            Paper on Food Safety was presented by David Byrne, at the time
77  III,    10.  4.  2   |  conclusions of the inspections are presented in reports that are, in
78  III,    10.  5.  1   |           human settlement areas is presented and discussed.~ ~
79  III,    10.  5.  2   |          are used.~Many of the data presented in this chapter are based
80  III,    10.  5.  2   |             health. The results are presented here below and indicate
81  III,    10.  5.  3   |           production losses will be presented.~ ~Absence from work~According
82  III,    10.  6.  1   |            the results of which are presented per social support categories.~ ~
83  III,    10.  6.  2   |           community level. Examples presented here resulted from a mapping
84   IV,    11.  5.  4   |           option of donation is not presented to relatives.~In some Member
85   IV,    12.  2       |           Nurses in Diabetes (FEND) presented the paperDiabetes: EU
86   IV,    12.  5       |             other health indicators presented by the different international
87   IV,    12. 10       |        years. Tables and graphs are presented which summarise information
88   IV,    12. 10       |             areas but these are not presented here. All determinants with
89   IV,    13.  2.  4   |          diseases.~ ~The WHO (2005) presented estimates of the Burden
90   IV,    13.  7.  1   |           be provided. The analysis presented in the above-mentioned document